Improved Patient Outcomes after Pharmacist Interventions in Eradication of H. Pylori Linked Gastric Ulcer

Authors: Saleha Sadeeqa

Volume 4, Issue 1

Abstract

Peptic ulcer is disruption in the innermost lining of stomach or primary portion of small intestine (duodenum) and occasionally lower esophagus. Clinical presentations of a gastric or duodenal ulcer involves upper abdominal pain called epigastric pain and complications comprises of bleeding, gastric perforation and obstruction of stomach and common etiological factors include bacteria (Helicobacter pylori) and non-steroidal anti-inflammatory drugs. Histological examination, Urea breathe test and serological testing reveals the presence of Helicobacter pylori. Triple regimen where proton pump inhibitor and clarithromycin can be along with either amoxicillin or metronidazole. In this case study, referred patient of 40 years old male is complaining about epigastric pain and diagnosed with H. pylori associated gastric ulcer along with comorbidity of type 2 diabetes and he was treated by eradication therapy or triple therapy (Amoxicillin, clarithromycin and omeprazole) along with life style amendments followed by clinical pharmacist which finally stabilizes his epigastric pain and condition of gastric ulcer.

Keywords: Eradication therapy; Patient outcomes; Gastric ulcer; Pharmacist interventions; H. pylori

View PDF